Published in Blood Transfus on January 01, 2009
Increases in levels of schistosome-specific immunoglobulin E and CD23(+) B cells in a cohort of Kenyan children undergoing repeated treatment and reinfection with Schistosoma mansoni. J Infect Dis (2010) 1.08
Immune Responses to pneumococcal vaccines in children and adults: Rationale for age-specific vaccination. Aging Dis (2011) 0.93
Multi-parametric flow cytometric and genetic investigation of the peripheral B cell compartment in human type 1 diabetes. Clin Exp Immunol (2014) 0.92
Identification of a sub-population of B cells that proliferates after infection with Epstein-Barr virus. Virol J (2011) 0.85
A novel B cell population revealed by a CD38/CD24 gating strategy: CD38(-)CD24 (-) B cells in centenarian offspring and elderly people. Age (Dordr) (2012) 0.83
Immunosenescence, inflammation and Alzheimer's disease. Longev Healthspan (2012) 0.82
Natural Antibodies as Rheostats for Susceptibility to Chronic Diseases in the Aged. Front Immunol (2016) 0.76
Elevated monocyte phosphorylated p38 in nearby employees after a chemical explosion. Sci Rep (2016) 0.75
Immunosenescence in renal transplantation: a changing balance of innate and adaptive immunity. Curr Opin Organ Transplant (2015) 0.75
The anti-aging effects of LW-AFC via correcting immune dysfunctions in senescence accelerated mouse resistant 1 (SAMR1) strain. Oncotarget (2016) 0.75
Changes in Circulating B Cell Subsets Associated with Aging and Acute SIV Infection in Rhesus Macaques. PLoS One (2017) 0.75
Origins and functions of B-1 cells with notes on the role of CD5. Annu Rev Immunol (2001) 3.65
Diagnostic criteria for monoclonal B-cell lymphocytosis. Br J Haematol (2005) 3.50
Infrequent normal B lymphocytes express features of B-chronic lymphocytic leukemia. J Exp Med (1982) 3.25
B4, a human B lymphocyte-associated antigen expressed on normal, mitogen-activated, and malignant B lymphocytes. J Immunol (1983) 3.09
Evidence for a large compartment of IgM-expressing memory B cells in humans. Blood (1997) 2.64
B1b lymphocytes confer T cell-independent long-lasting immunity. Immunity (2004) 2.60
B1 cells: similarities and differences with other B cell subsets. Curr Opin Immunol (2001) 2.57
B-cell chronic lymphocytic leukemia cells express a surface membrane phenotype of activated, antigen-experienced B lymphocytes. Blood (2002) 1.94
B cells are generated throughout life in humans. J Immunol (1996) 1.47
Antibody-mediated regulation of the immune response. Scand J Immunol (2006) 1.32
The structure of human CD23 and its interactions with IgE and CD21. J Exp Med (2005) 1.28
The REALAB project: a new method for the formulation of reference intervals based on current data. Clin Chem (2005) 1.21
CD5 expression in human B-cell populations. Immunol Today (1999) 1.15
The CD5+ B-cell. Int J Biochem Cell Biol (2004) 1.00
CD23 and B-cell activation. Curr Opin Immunol (1995) 0.97
Maturation of B cell precursors is impaired in thymic-deprived nude and old mice. J Immunol (1998) 0.93
T helper cell-induced CD23 (BLAST-2) expression: an activation marker for the high density fraction of human B cells. Clin Immunol Immunopathol (1989) 0.91
Extensive analysis of lymphocyte subsets in normal subjects by three-color immunofluorescence. Nouv Rev Fr Hematol (1991) 0.90
Loss of CD34(+) hematopoietic progenitor cells due to washing can be reduced by the use of fixative-free erythrocyte lysing reagents. J Immunol Methods (2000) 0.89
Induction of B cell apoptosis by co-cross-linking CD23 and sIg involves aberrant regulation of c-myc and is inhibited by bcl-2. Int Immunol (1997) 0.89
The mosaic of B-cell subsets (with special emphasis on primary Sjögren's syndrome). Autoimmun Rev (2006) 0.89
Function of CD23 in the response of human B cells to antigen. Eur J Immunol (1997) 0.86
Changes of human B and B-1a peripheral blood lymphocytes with age. Hematology (2007) 0.85
IgE expression on the surface of B1 and B2 lymphocytes in experimental murine schistosomiasis. Braz J Med Biol Res (2005) 0.83
BRAF mutations in hairy-cell leukemia. N Engl J Med (2011) 7.05
Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells. Stem Cells (2005) 4.26
Somatically acquired JAK1 mutations in adult acute lymphoblastic leukemia. J Exp Med (2008) 3.24
G-CSF-stimulated neutrophils are a prominent source of functional BLyS. J Exp Med (2003) 2.31
NASH predicts plasma inflammatory biomarkers independently of visceral fat in men. Obesity (Silver Spring) (2008) 2.23
Prognostic impact of c-KIT mutations in core binding factor leukemias: an Italian retrospective study. Blood (2005) 1.87
HB-EGF/HER-1 signaling in bone marrow mesenchymal stem cells: inducing cell expansion and reversibly preventing multilineage differentiation. Blood (2005) 1.62
Adverse reactions in blood and apheresis donors: experience from two Italian transfusion centres. Blood Transfus (2009) 1.62
AIDA 0493 protocol for newly diagnosed acute promyelocytic leukemia: very long-term results and role of maintenance. Blood (2011) 1.59
Cancers in patients with hemophilia: a retrospective study from the Italian Association of Hemophilia Centers. J Thromb Haemost (2012) 1.57
Clonal mast cell disorders in patients with systemic reactions to Hymenoptera stings and increased serum tryptase levels. J Allergy Clin Immunol (2009) 1.57
How I treat rare venous thromboses. Blood (2008) 1.56
Efficacy of Helicobacter pylori eradication in raising platelet count in adult patients with idiopathic thrombocytopenic purpura. Haematologica (2002) 1.54
Mesenchymal stem cells for bone, cartilage, tendon and skeletal muscle repair. Bone (2006) 1.50
Quality and reliability of routine coagulation testing: can we trust that sample? Blood Coagul Fibrinolysis (2006) 1.50
Induction of neural-like differentiation in human mesenchymal stem cells derived from bone marrow, fat, spleen and thymus. Bone (2006) 1.49
Effects on health of air pollution: a narrative review. Intern Emerg Med (2015) 1.48
The syndrome of the "obsessive-compulsory scientist": a new mental disorder? Clin Chem Lab Med (2013) 1.47
Together we care: new challenges for global haemophilia treatment centers. Indian J Med Res (2009) 1.44
Routine coagulation tests in newborn and young infants. J Thromb Thrombolysis (2007) 1.42
Recombinant human erythropoietin facilitates autologous blood collections in children undergoing corrective spinal surgery. Transfusion (2004) 1.42
Differential response of human basophil activation markers: a multi-parameter flow cytometry approach. Clin Mol Allergy (2008) 1.42
Phlebotomy issues and quality improvement in results of laboratory testing. Clin Lab (2006) 1.41
Mental depression and cardiovascular disease: a multifaceted, bidirectional association. Semin Thromb Hemost (2009) 1.39
The growing impact of publications in haemostasis and thrombosis journals. Thromb Haemost (2007) 1.38
Bone marrow stromal cells and the upregulation of interleukin-8 production in human T-cell acute lymphoblastic leukemia through the CXCL12/CXCR4 axis and the NF-kappaB and JNK/AP-1 pathways. Haematologica (2008) 1.35
In celiac disease, a subset of autoantibodies against transglutaminase binds toll-like receptor 4 and induces activation of monocytes. PLoS Med (2006) 1.34
The paradoxical relationship between serum uric acid and cardiovascular disease. Clin Chim Acta (2008) 1.33
Regenerative and immunomodulatory potential of mesenchymal stem cells. Curr Opin Pharmacol (2006) 1.33
The role of ethnicity, age and gender in venous thromboembolism. J Thromb Thrombolysis (2010) 1.24
CCR3 as a single selection marker compared to CD123/HLADR to isolate basophils in flow cytometry: some comments. Cytometry A (2010) 1.23
Toll-like receptor-3-activated human mesenchymal stromal cells significantly prolong the survival and function of neutrophils. Stem Cells (2011) 1.22
Effect of Helicobacter pylori eradication on platelet count in idiopathic thrombocytopenic purpura: a systematic review and meta-analysis. J Antimicrob Chemother (2007) 1.19
Prophylaxis in people with haemophilia. Thromb Haemost (2009) 1.19
Immune regulation by mesenchymal stem cells derived from adult spleen and thymus. Stem Cells Dev (2007) 1.19
Immunology and homeopathy. 2. Cells of the immune system and inflammation. Evid Based Complement Alternat Med (2006) 1.19
Clinical usefulness of measuring red blood cell distribution width on admission in patients with acute coronary syndromes. Clin Chem Lab Med (2009) 1.19
Long-term effects of amino-bisphosphonates on circulating γδ T cells. Calcif Tissue Int (2012) 1.18
An unusual case of a spurious, transfusion-acquired haemoglobin S. Blood Transfus (2010) 1.16
Macrophages may promote cancer growth via a GM-CSF/HB-EGF paracrine loop that is enhanced by CXCL12. Mol Cancer (2010) 1.16
Immunology and homeopathy. 1. Historical background. Evid Based Complement Alternat Med (2005) 1.15
Arterial thrombus formation in cardiovascular disease. Nat Rev Cardiol (2011) 1.15
Non-O blood type is the commonest genetic risk factor for VTE: results from a meta-analysis of the literature. Semin Thromb Hemost (2012) 1.15
Haemorrhage and amyloidosis. Br J Haematol (2012) 1.14
Immunology and homeopathy. 3. Experimental studies on animal models. Evid Based Complement Alternat Med (2006) 1.14
Increased risk of CKD among type 2 diabetics with nonalcoholic fatty liver disease. J Am Soc Nephrol (2008) 1.12
Reductive activation of ricin and ricin A-chain immunotoxins by protein disulfide isomerase and thioredoxin reductase. Biochem Pharmacol (2004) 1.11
Increased mean platelet volume in patients with acute coronary syndromes. Arch Pathol Lab Med (2009) 1.11
Doping in competition or doping in sport? Br Med Bull (2008) 1.11
Combination of rituximab, bendamustine, and cytarabine for patients with mantle-cell non-Hodgkin lymphoma ineligible for intensive regimens or autologous transplantation. J Clin Oncol (2013) 1.10
Rituximab improves the efficacy of high-dose chemotherapy with autograft for high-risk follicular and diffuse large B-cell lymphoma: a multicenter Gruppo Italiano Terapie Innnovative nei linfomi survey. J Clin Oncol (2008) 1.10
Influence of a light meal on routine haematological tests. Blood Transfus (2010) 1.10
Impact of immune thrombocytopenia on the clinical course of chronic lymphocytic leukemia. Blood (2007) 1.09
Imatinib and regression of type 2 diabetes. N Engl J Med (2005) 1.09
Notch-3 and Notch-4 signaling rescue from apoptosis human B-ALL cells in contact with human bone marrow-derived mesenchymal stromal cells. Blood (2011) 1.08
Neutrophil activation and survival are modulated by interaction with NK cells. Int Immunol (2010) 1.08
The role of anti-core antibody response in the detection of occult hepatitis B virus infection. Clin Chem Lab Med (2010) 1.06
The prostate specific membrane antigen regulates the expression of IL-6 and CCL5 in prostate tumour cells by activating the MAPK pathways. PLoS One (2009) 1.06
Human neutrophils interact with both 6-sulfo LacNAc+ DC and NK cells to amplify NK-derived IFN{gamma}: role of CD18, ICAM-1, and ICAM-3. Blood (2010) 1.05
Moderate red wine consumption and cardiovascular disease risk: beyond the "French paradox". Semin Thromb Hemost (2010) 1.05
p38 MAPK is a critical regulator of the constitutive and the beta4 integrin-regulated expression of IL-6 in human normal thymic epithelial cells. Eur J Immunol (2003) 1.05
A systematic overview of the first pasteurised VWF/FVIII medicinal product, Haemate P/ Humate -P: history and clinical performance. Eur J Haematol Suppl (2008) 1.04
Isolated bone marrow mastocytosis: an underestimated subvariant of indolent systemic mastocytosis. Haematologica (2010) 1.04
Anti-tumor effects of toxins targeted to the prostate specific membrane antigen. Prostate (2002) 1.03
Biochemistry, physiology, and complications of blood doping: facts and speculation. Crit Rev Clin Lab Sci (2006) 1.03
Vaccine adverse event monitoring systems across the European Union countries: time for unifying efforts. Vaccine (2009) 1.02
IFN-gamma-mediated upmodulation of MHC class I expression activates tumor-specific immune response in a mouse model of prostate cancer. Vaccine (2010) 1.02
How to write a scientific manuscript for publication. Blood Transfus (2012) 1.02
Flow cytometric study of potential target antigens (CD19, CD20, CD22, CD33) for antibody-based immunotherapy in acute lymphoblastic leukemia: analysis of 552 cases. Leuk Lymphoma (2011) 1.01
Clinico-biological features of 5202 patients with acute lymphoblastic leukemia enrolled in the Italian AIEOP and GIMEMA protocols and stratified in age cohorts. Haematologica (2013) 1.01
On the cytokines produced by human neutrophils in tumors. Semin Cancer Biol (2013) 1.01
Help me, Doctor! My D-dimer is raised. Ann Med (2008) 1.01
Mesenchymal stem cells: from biology to clinical use. Blood Transfus (2007) 1.00
Novel stem/progenitor cells with neuronal differentiation potential reside in the leptomeningeal niche. J Cell Mol Med (2009) 1.00
Thrombotic complications of erythropoiesis-stimulating agents. Semin Thromb Hemost (2010) 1.00
Immunology and homeopathy. 4. Clinical studies-part 1. Evid Based Complement Alternat Med (2006) 0.99
Influenza and cardiovascular disease: does swine-origin, 2009 H1N1 flu virus represent a risk factor, an acute trigger, or both? Semin Thromb Hemost (2010) 0.99
Methodological approach to minimal residual disease detection by flow cytometry in adult B-lineage acute lymphoblastic leukemia. Haematologica (2006) 0.98
Absence of prognostic impact of CD13 and/or CD33 antigen expression in adult acute lymphoblastic leukemia. Results of the GIMEMA ALL 0496 trial. Haematologica (2007) 0.98
Identification of spurious hemolysis in anticoagulated blood with Sysmex XE-2100 and Siemens Advia 2120. Clin Lab (2012) 0.98
Splenic marginal zone lymphoma with or without villous lymphocytes. Hematologic findings and outcomes in a series of 57 patients. Cancer (2004) 0.97
Most cases of primary salivary mucosa-associated lymphoid tissue lymphoma are associated either with Sjoegren syndrome or hepatitis C virus infection. Br J Haematol (2004) 0.97
Clinical use of Haemate P in inherited von Willebrand's disease: a cohort study on 100 Italian patients. Haematologica (2007) 0.97
Platelet gel in the treatment of cutaneous ulcers: the experience of the Immunohaematology and Transfusion Centre of Parma. Blood Transfus (2010) 0.96
Stability of blood cell counts, hematologic parameters and reticulocytes indexes on the Advia A120 hematologic analyzer. J Lab Clin Med (2005) 0.96
Determinants of anaemia in the very elderly: a major contribution from impaired renal function? Blood Transfus (2010) 0.96
Immunology and homeopathy. 4. Clinical studies-part 2. Evid Based Complement Alternat Med (2006) 0.96
CD20 expression in Hodgkin and Reed-Sternberg cells of classical Hodgkin's disease: associations with presenting features and clinical outcome. J Clin Oncol (2002) 0.96
Diagnosis and management of ischemic heart disease. Semin Thromb Hemost (2013) 0.94
Evidence-based recommendations on the treatment of von Willebrand disease in Italy. Blood Transfus (2009) 0.94